Bexsero Update
BEXSERO® supplies have returned to normal. We have contacted everyone on our waiting list. If you are interesting in commencing the BEXSERO® schedule, please contact our friendly reception team or book an appointment online to discuss this with your Doctor.
What is BEXSERO® and what is it used for?
BEXSERO® is a meningococcal group B vaccine.
BEXSERO® is given to individuals from 2 months of age and older to help protect against disease caused by bacteria called Neisseria meningitidis group B. These bacteria can cause serious, and sometimes life-threatening, infections such as meningitis (inflammation of the covering of the brain and spinal cord) and sepsis (blood poisoning).
The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person. This results in protection against this disease.
Who should consider having the BEXSERO® immunisation?
Based on their higher disease risk, 4CMenB is recommended for these groups:
- Infants and young children, particularly those aged <24 months
- Adolescents aged 15 to 19 years
- Children and adults with medical conditions that place them at a high risk of IMD, such as functional or anatomical asplenia or complement component disorders
- Laboratory personnel who frequently handle Neisseria meningitidis
